These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28457074)

  • 1. Nephrolithiasis in Israel: Epidemiological Characteristics of Return Patients in a Tertiary Care Center.
    Abu-Ghanem Y; Kleinmann N; Winkler HZ; Zilberman DE
    Isr Med Assoc J; 2016 Dec; 18(12):725-728. PubMed ID: 28457074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-h urine metabolic profile: is it necessary in all kidney stone formers?
    Abu-Ghanem Y; Shvero A; Kleinmann N; Winkler HZ; Zilberman DE
    Int Urol Nephrol; 2018 Jul; 50(7):1243-1247. PubMed ID: 29876775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
    McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
    Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
    Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
    J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study.
    Lieske JC; de la Vega LS; Gettman MT; Slezak JM; Bergstralh EJ; Melton LJ; Leibson CL
    Am J Kidney Dis; 2006 Dec; 48(6):897-904. PubMed ID: 17162144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
    Hadian B; Zafar-Mohtashami A; Ghorbani F
    Iran J Kidney Dis; 2018 Jan; 12(1):22-26. PubMed ID: 29421773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.
    Abu-Ghanem Y; Kleinmann N; Erlich T; Winkler HZ; Zilberman DE
    Isr Med Assoc J; 2021 Jan; 23(1):12-16. PubMed ID: 33443336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new epidemiology of nephrolithiasis.
    Shoag J; Tasian GE; Goldfarb DS; Eisner BH
    Adv Chronic Kidney Dis; 2015 Jul; 22(4):273-8. PubMed ID: 26088071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?
    Mirheydar HS; Banapour P; Massoudi R; Palazzi KL; Jabaji R; Reid EG; Millard FE; Kane CJ; Sur RL
    Int Braz J Urol; 2014; 40(6):772-80. PubMed ID: 25615245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic background has minimal impact on the etiology of nephrolithiasis.
    Maloney ME; Springhart WP; Ekeruo WO; Young MD; Enemchukwu CU; Preminger GM
    J Urol; 2005 Jun; 173(6):2001-4. PubMed ID: 15879804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.
    Hartman C; Friedlander JI; Moreira DM; Elsamra SE; Smith AD; Okeke Z
    BJU Int; 2015 Apr; 115(4):619-24. PubMed ID: 24823472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.